Rangers place Mike Napoli on disabled list with oblique strain

Leave a comment

Jeff Wilson of the Fort Worth Star-Telegram passes along notice that the Rangers have placed catcher Mike Napoli on the 15-day disabled list with a strained oblique muscle and recalled Taylor Teagarden from Triple-A Round Rock.

Napoli is likely to miss at least three weeks and could be out for as long as a month. The 29-year-old has a healthy .221/.344/.493 batting line through 163 plate appearances this season with 10 home runs and 25 RBI. He’s started 20 games at catcher, 14 games at first base and five games at DH.

Yorvit Torrealba is starting behind the plate in Sunday’s series finale against the Twins and is likely to serve as the Rangers’ primary catcher for the rest of June. Teagarden will operate as Torrealba’s backup, making infrequent starts.

Blue Jays sign Danny Espinosa to minors deal

Getty Images
Leave a comment

Free agent middle infielder Danny Espinosa signed a minor-league deal with the Blue Jays, the team announced Saturday. The deal includes an invite to spring training, where Espinosa is scheduled for his first split-squad game against the Orioles this afternoon.

Espinosa, 30, was inked to another minor-league deal with the Yankees in January. The veteran infielder was competing for an infield job until the team picked up second baseman Neil Walker on a one-year, $4 million deal last Monday. Prior to his release, he slashed .160/.276/.320 with one home run through his first 12 games with the Yankees this spring. He didn’t fare much better in the majors last year, either, batting a cumulative .173/.245/.278 with six home runs and a .523 OPS in 295 PA for the Mariners and Rays.

Blue Jays starting shortstop Troy Tulowitzki is still dealing with a bone spur in his heel and has officially been ruled out for Opening Day, which could clear a path for Espinosa to claim a starting role in Toronto. Of course, he won’t be the only candidate under consideration — Yangervis Solarte and Aledmys Diaz are still in the mix as well, though no final decision appears to be made just yet.